Fluvoxamine augmentation in clozapine-resistant schizophrenia: An open pilot study

被引：38

作者：

Silver, H

Kushnir, M

Kaplan, A

机构：

[1] Flugelman (Mazra) Psychiat. Hospital, Doar Na Ashrat

[2] Flugelman (Mazra) Psychiat. Hospital, Doar Na Ashrat

来源：

BIOLOGICAL PSYCHIATRY | 1996年 / 40卷 / 07期

关键词：

clozapine; treatment-resistant; schizophrenia; augmentation; SSRI;

D O I：

10.1016/0006-3223(96)00170-9

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：671 / 674

页数：4

共 15 条

[1]

Andreasen N, 1984, SCALE ASSESSMENT POS

[2]

DANIEL DG, 1994, J CLIN PSYCHOPHARM, V14, P340

[3] A PLACEBO-CONTROLLED TRIAL OF FLUOXETINE ADDED TO NEUROLEPTIC IN PATIENTS WITH SCHIZOPHRENIA [J].

GOFF, DC ;

MIDHA, KK ;

SARIDSEGAL, O ;

HUBBARD, JW ;

AMICO, E .

PSYCHOPHARMACOLOGY, 1995, 117 (04) :417-423

[4]

GOFF DC, 1991, AM J PSYCHIAT, V148, P790

[5]

Guy W., 1976, ASSESSMENT MANUAL PS

[6]

HIEMKE C, 1994, J CLIN PSYCHOPHARM, V14, P279

[7] FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J].

JERLING, M ;

LINDSTROM, L ;

BONDESSON, U ;

BERTILSSON, L .

THERAPEUTIC DRUG MONITORING, 1994, 16 (04) :368-374

[8] THE IMPORTANCE OF SEROTONIN DOPAMINE INTERACTIONS IN THE ACTION OF CLOZAPINE [J].

MELTZER, HY .

BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :22-29

[9]

MELTZER HY, 1990, HOSP COMMUNITY PSYCH, V41, P892

[10]

OVERALL JE, 1962, PSYCHOL REP, V10, P799

← 1 2 →